Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2Elena Ortíz-Zapater, Pilar Navarro|American Journal Of Pathology|2007Cited by 76
The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancerNeus Martínez‐Bosch, Pilar Navarro|Oncotarget|2016Cited by 11
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunityNeus Martínez‐Bosch, Pilar Navarro|Science Advances|2026Cited by 0